54A Stock Overview

Cann Global Limited engages in the production and distribution of medicinal cannabis medications, natural foods, and cosmeceuticals in Australia and internationally. More details

54A fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Risk Analysis

Earnings have declined by 13% per year over past 5 years

Does not have a meaningful market cap (€8M)

Makes less than USD$1m in revenue (A$980K)

Highly volatile share price over the past 3 months

+ 1 more risk

My Notes

Capture your thoughts, links and company narrative

Cann Global Limited Competitors

Biofrontera

XTRA:B8FK

€13.1m

SynBiotic

DUSE:SBX

€22.0m

TFF Pharmaceuticals

MUN:0K30

€9.7m

Cantourage Group

XTRA:HIGH

€61.1m

Price History & Performance

Summary of share price highs, lows and changes for Cann Global
Historical stock prices
Current Share Price	AU$0.013
52 Week High	AU$0.25
52 Week Low	AU$0.011
Beta	1.27
1 Month Change	-46.00%
3 Month Change	8.00%
1 Year Change	-86.50%
3 Year Change	-97.43%
5 Year Change	-89.20%
Change since IPO	-99.56%

Recent updates

Shareholder Returns

	54A	DE Pharmaceuticals	DE Market
7D	-3.6%	2.2%	0.7%
1Y	-86.5%	-16.8%	8.4%

Return vs Industry: 54A underperformed the German Pharmaceuticals industry which returned -28.2% over the past year.

Return vs Market: 54A underperformed the German Market which returned 5.9% over the past year.

Price Volatility

Is 54A's price volatile compared to industry and market?
54A volatility
54A Average Weekly Movement	35.3%
Pharmaceuticals Industry Average Movement	5.5%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	12.0%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: 54A's share price has been volatile over the past 3 months.

Volatility Over Time: 54A's weekly volatility has decreased from 192% to 35% over the past year, but is still higher than 75% of German stocks.

About the Company

Founded	Employees	CEO	Website
2007	n/a	Sholom Feldman	www.canngloballimited.com

Cann Global Limited operates in medicinal cannabis and hemp food industries in Australia and internationally. The company operates through Hemp and Medical Cannabis Products, and Mining Exploration and Evaluation segments. It grows and cultivates hemp and medical cannabis products; and provides plant-based food and skincare products.

Cann Global Limited Fundamentals Summary

How do Cann Global's earnings and revenue compare to its market cap?
54A fundamental statistics
Market cap	€5.23m
Earnings (TTM)	-€3.34m
Revenue (TTM)	€659.78k

7.9x

P/S Ratio

-1.6x

P/E Ratio

Is 54A overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
54A income statement (TTM)
Revenue	AU$980.09k
Cost of Revenue	AU$752.05k
Gross Profit	AU$228.03k
Other Expenses	AU$5.19m
Earnings	-AU$4.97m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

Mar 07, 2022

Earnings per share (EPS)	-0.019
Gross Margin	23.27%
Net Profit Margin	-506.61%
Debt/Equity Ratio	0.7%

How did 54A perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2022/03/05 09:26
End of Day Share Price	2022/03/04 00:00
Earnings	2021/12/31
Annual Earnings	2021/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cann Global Limited is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution